Diversified Trust CO Theravance Biopharma, Inc. Transaction History

Diversified Trust CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$8.41 - $10.34 $101,946 - $125,341	-12,122 Closed	0 $0
Q1 2022 Apr 07, 2022	BUY	$8.33 - $12.96 $100,976 - $157,101	12,122 New	12,122 $116,000
Q4 2021 Jan 13, 2022	SELL	$7.42 - $11.05 $109,229 - $162,667	-14,721 Closed	0 $0
Q3 2021 Jan 13, 2022	BUY	$6.77 - $14.41 $99,661 - $212,129	14,721 New	14,721 $109,000

122

47.3M

200

12.8K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $629M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

Stay updated on Diversified Trust CO with notifications on news.